A review of the biology and toxicologic implications of the induction of lysosomal lamellar bodies by drugs

Abraham, 1968, Formation of myeloid bodies in rat liver lysosomes after chloroquine administration, Exp. Mol. Pathol., 9, 212, 10.1016/0014-4800(68)90037-3 Abraham, 1970, Effects of chloroquine treatment on lysosomes of rat liver cells, Exp. Mol. Pathol., 12, 148, 10.1016/0014-4800(70)90046-8 Adams, 1986, Peripheral neutrophil inclusions in amiodarone treated patients, Brit. J. Clin. Pharmacol., 22, 736, 10.1111/j.1365-2125.1986.tb02968.x Akeda, 1972, A study on the lipidosis induced by a coronary vasodilator, 4,4′-diethylaminoethoxyhexestrol dihydrochloride, Mie Med. J., 22, 65 Aubert-Tulkens, 1979, Gentamicin-induced lysosomal phospholipidosis in cultured rat fibroblasts, Lab. Invest., 40, 481 Caldwell, 1975, Species variations in the N-oxidation of chlorphentermine, Biochem. Pharmacol., 24, 2225, 10.1016/0006-2952(75)90259-2 de Duve, 1974, Lysosomotropic agents, Biochem. Pharmacol., 23, 2495, 10.1016/0006-2952(74)90174-9 DiDio, 1972, The ubiquity of “myelin figures” as seen with electron microscopy, Atenes Parmense Acta Biomed, 43, 341 Dingell, 1964, Species differences in the metabolism of imipramine and desmethylimipramine (DMI), J. Pharmacol. Exp. Ther., 143, 14 Drenckhahn, 1976, Lysosomal alterations in cultured macrophages exposed to anorexigenic and psychotropic drugs, Lab. Invest., 35, 116 Drenckhahn, 1977, Lens opacities associated with lipidosis-like ultrastructural alterations in rats treated with chloroquine, chlorphentermine or iprindole, Exp. Eye Res., 24, 621, 10.1016/0014-4835(77)90120-8 Essien, 1986, Effects of chloroquine and didesethylchloroquine on rabbit myocardium and mitochondria, J. Pharm. Pharmacol., 38, 543, 10.1111/j.2042-7158.1986.tb04635.x Estes, 1987, Chloroquine neuromyopathy, Amer. J. Med., 82, 447, 10.1016/0002-9343(87)90444-X Hostetler, 1984, Molecular studies of the induction of cellular phospholipidosis by cationic amphiphilic drugs, 43, 2582 Hostetler, 1985, Chloroquine-induced phospholipid fatty liver: Measurement of drug and lipid concentrations in rat liver lysosomes, J. Biol. Chem., 260, 215, 10.1016/S0021-9258(18)89718-6 Hruban, 1972, Drug-induced naturally occurring myeloid bodies, Lab. Invest., 27, 62 Hruban, 1984, Pulmonary and generalized lysosomal storage induced by amphiphilic drugs, Environ. Health Perspect., 55, 53, 10.1289/ehp.845553 Itoh, 1973, Clinico-pathological and electron microscopic studies on a coronary dilating agent: 4,4′-Diethylaminoethoxyhexestro-induced liver injuries, Acta Hepato-Gastroenterol, 20, 204 Jagel, 1984, Lipidosis-like alterations in cultured macrophages exposed to local anesthetics, Arch. Toxicol., 55, 229, 10.1007/BF00341016 Kaloyanides, 1980, Aminoglycoside nephrotoxicity, Kidney Int., 18, 571, 10.1038/ki.1980.175 Kirby, 1962, Cataract formation after triparanol therapy, Arch. Ophthalmol., 68, 486, 10.1001/archopht.1962.00960030490010 Kubo, 1985, Mechanism of cationic amphiphilic drug inhibition of purified lysosomal phospholipase A1, Biochemistry, 24, 6515, 10.1021/bi00344a031 Kubo, 1987, Metabolic basis of diethylaminoethoxyhexestrol-induced phospholipid fatty liver, Amer. J. Physiol., 252, E375 Lehnert, 1983, Particle binding, phagocytosis, and plastic substrate adherence characteristics of alveolar macrophages from rats acutely treated with chlorphentermine, J. Reticuloendothel. Soc., 33, 293 Liu, 1986, Amiodarone pulmonary toxicity: Functional and ultrastructural evaluation, Thorax, 41, 100, 10.1136/thx.41.2.100 Lüllmann-Rauch, 1974, Chlorphentermine-induced lipidosislike ultrastructural alterations in lungs and adrenal glands of several species, Toxicol. Appl. Pharmacol., 30, 408, 10.1016/0041-008X(74)90263-4 Lüllmann-Rauch, 1975, Chlorphentermine-induced abnormal cytoplasmic inclusions in peripheral blood cells of rats and guinea pigs, Toxicol. Appl. Pharmacol., 32, 32, 10.1016/0041-008X(75)90192-1 Lüllmann-Rauch, 1975, Intraalveolar foam cells associated with lipidosis-like alterations in lung and liver of rats treated with tricyclic psychotropic drugs, Virchows Arch. B, 19, 255 Lüllmann, 1975, Drug-induced phospholipidosis, Crit. Rev. Toxicol., 4, 185, 10.1080/10408447509164014 Lüllmann, 1978, Lipidosis induced by amphiphilic cationic drugs, Biochem. Pharmacol., 27, 1103, 10.1016/0006-2952(78)90435-5 Lüllmann-Rauch, 1979, Drug-induced lysosomal storage disorders, 49 Lüllmann-Rauch, 1982, Generalized lipidosis in newborn rats and guinea pigs induced during prenatal development by administration of amphiphilic drugs to pregnant animals, Virchows Arch. B, 39, 59, 10.1007/BF02892837 Lüllmann-Rauch, 1987, Fusion of storage lysosomes in experimental lipidosis and glycogenosis, Exp. Mol. Pathol., 46, 136, 10.1016/0014-4800(87)90037-2 Matsuzawa, 1980, Studies on drug-induced lipidosis: Subcellular localization of phospholipid and cholesterol in the liver of rats treated with chloroquine or 4,4′,bis(diethylaminoethoxy)diethyldiphenylethane, J. Lipid Res., 21, 202, 10.1016/S0022-2275(20)39826-6 McNulty, 1981, Enhanced phagocytic and bactericidal activities of phospholipidotic rat alveolar macrophages, J. Reticuloendothel. Soc., 30, 539 Ohkuma, 1978, Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents, 75, 3327 Powell, 1982, In vitro response of rat and human kidney lysosomes to aminoglycosides, Biochem. Pharmacol., 31, 3447, 10.1016/0006-2952(82)90625-6 Ratliff, 1987, Diagnosis of chloroquine cardiomyopathy by endocardial biopsy, N. Engl. J. Med., 316, 191, 10.1056/NEJM198701223160405 Reasor, 1980, Chemiluminescence from rat alveolar macrophages following induction of phospholipidosis with chlorphentermine, Toxicol. Appl. Pharmacol., 52, 497, 10.1016/0041-008X(80)90344-0 Reasor, 1981, Drug-induced lipidosis and the alveolar macrophage, Toxicology, 20, 1, 10.1016/0300-483X(81)90102-5 Reasor, 1984, Phospholipidosis in the alveolar macrophage induced by cationic amphiphilic drugs, 43, 2578 Reasor, 1981, Recovery from chlorphentermine-induced phospholipidosis in rat alveolar macrophages: Morphological features, Exp. Mol. Pathol., 35, 370, 10.1016/0014-4800(81)90020-4 Reasor, 1984, Effects of cationic amphiphilic drugs on the developing animal, 69 Reasor, 1987, Role of the alveolar macrophage in the induction of pulmonary phospholipidosis: Pharmacologic and toxicologic considerations, Vol. 2, 43 Reasor, 1988, Amiodarone-induced phospholipidosis in rat alveolar macrophages, Amer. Rev. Respir. Dis., 137, 510, 10.1164/ajrccm/137.3.510 Ridout, 1986, Influence of agents that alter lysosomal function of fetal mouse hearts recovering from anoxia and substrate depletion, J. Mol. Cell. Cardiol., 18, 867, 10.1016/S0022-2828(86)80960-9 Sauers, 1986, Morphological and functional changes in mouse splenic lymphocytes following in vivo and in vitro exposure to chlorphentermine, J. Immunopharmacol., 8, 611, 10.3109/08923978609026508 Sauers, 1988, Chlorphentermine suppresses the phosphatidylinositol pathway in concanavalin A-activated mouse splenic lymphocytes, Immunopharmacol. Immunotoxicol., 10, 1, 10.3109/08923978809014398 Seydel, 1976, NMR studies on the molecular basis of drug-induced phopholipidosis-II. Interaction between several amphiphilic drugs and phospholipids, Biochem. Pharmacol., 25, 2357, 10.1016/0006-2952(76)90028-9 Smith, 1973, Electron microscopy of chlorphentermine lung, Thorax, 28, 559, 10.1136/thx.28.5.559 Somani, 1986, Amiodarone-associated changes in human neutrophils, Amer. J. Cardiol., 57, 666, 10.1016/0002-9149(86)90856-8 Staubli, 1978, Some properties of myeloid bodies induced in rat liver by an antidepressant drug (maprotiline), Exp. Mol. Pathol., 28, 177, 10.1016/0014-4800(78)90050-3 Wibo, 1974, Protein degradation in cultured cells. II. The uptake of chloroquine by rat fibroblasts and inhibition of cellular protein degradation and cathepsin B1, J. Cell Biol., 63, 430, 10.1083/jcb.63.2.430 Wildenthal, 1978, Inhibition of protein degradation in mouse hearts by agents that cause lysosomal dysfunction, Circ. Res., 42, 787, 10.1161/01.RES.42.6.787